Figure 6.
OS according to gilteritinib Ctrough at steady state. OS is shown in patients stratified according to high (≥617 ng/mL) or low (<617 ng/mL) gilteritinib serum Ctrough at steady state. Tick marks indicate censored data. mOS, median OS.
OS according to gilteritinib Ctrough at steady state. OS is shown in patients stratified according to high (≥617 ng/mL) or low (<617 ng/mL) gilteritinib serum Ctrough at steady state. Tick marks indicate censored data. mOS, median OS.
